Salvatore Giordano
Latest contributions
TAVI: head-to-head trials
20 May 2026 – From EuroPCR 2026
This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...
TAVI via axillary access: a simple, effective approach
09 Mar 2026
When transfemoral access is not an option, the axillary route offers a fully percutaneous alternative for TAVI.
This step-by-step approach shows how to secure access and achieve reliable haemostasis using a combined suture- and plug-based strategy.
Author
Author
Author
Author
Author
Author
Author
Featured research - TAVI: MELA, ViMech & more
17 Nov 2025 – From PCR London Valves 2025
This session presents cutting-edge research on Transcatheter Aortic Valve Implantation (TAVI), focusing on comparative outcomes between Myval and Evolut valves in large aortic annuli, the role of balloon post-dilation in self- and balloon-expandable valves, and novel valve-in-mechanical valve replacement approaches. Long-term follow-up data contrasting surgical aortic...
Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice
17 Nov 2025 – From PCR London Valves 2025
Discover the essential takeaways from the Myval THV series for improving TAVI outcomes. Learn from high-volume operators how pre-procedural planning, imaging, and sizing rationale guide optimal patient management. See step-by-step implantation of the next-gen Myval Octapro+, including the OctaAlign technique, and understand how precise deployment and...
TAVI outcomes
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...
